TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Rhea-AI Summary
TransMedics (Nasdaq: TMDX) said members of its management team will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 3:00 pm PST / 6:00 pm EST. The presentation will be available live and as an archived webcast on the company’s Investors website. The company also noted its standard investor presentation is available at the same link.
Positive
- None.
Negative
- None.
News Market Reaction – TMDX
In the Dec 31 session, TMDX declined 0.22%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Dec 24 | Inducement grants | Negative | -2.2% | New employee inducement option and RSU grants under Nasdaq Rule 5635(c)(4). |
| Dec 09 | Operational collaboration | Positive | -1.3% | Strategic collaboration to deploy organ transport hubs and support infrastructure. |
| Nov 18 | Conference participation | Neutral | +3.2% | Management participation in Piper Sandler healthcare conference fireside chat. |
| Oct 31 | Inducement grants | Negative | -5.2% | Inducement equity awards with new options and RSUs for 15 employees. |
| Oct 29 | Quarterly earnings | Positive | +3.5% | Q3 2025 revenue and earnings growth with raised full‑year guidance. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Earnings and operational milestones have generally seen positive stock reactions, while inducement grant announcements have coincided with selloffs. One positive strategic update drew a negative move, indicating occasional divergence between favorable news and price action.
Over the last six months, TransMedics reported strong Q3 2025 results with revenue of $143.8 million, net income of $24.3 million, and raised full‑year revenue guidance to $595–$605 million, which aligned with a +3.55% move. Two inducement grant announcements in October and December 2025 were followed by declines of 5.18% and 2.2%. Participation in another healthcare conference in November coincided with a 3.24% gain, while a positive operational collaboration headline saw a 1.32% pullback, showing that upbeat updates have not always produced consistent upside.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Event: 44th Annual J.P. Morgan Healthcare Conference
Date: Monday, January 12, 2026
Time: 3:00 pm PST
A live and archived webcast of the presentations will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/. The Company's standard investor presentation is also available through this link.
About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in
Investor Contact:
Brian Johnston
Laine Morgan
332-895-3222
Investors@transmedics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-participate-in-the-44th-annual-jp-morgan-healthcare-conference-302650761.html
SOURCE TransMedics Group, Inc.